128 related articles for article (PubMed ID: 1942708)
1. [Application of the nucleolar organizer regions to urinary cytology and its computer-assisted image analysis].
Takeuchi T; Nagatani Y; Tada K; Sugiyama S; Koide T; Sakai S; Tanaka T; Mori H; Yamamoto N; Kobayashi S
Nihon Hinyokika Gakkai Zasshi; 1991 Sep; 82(9):1494-503. PubMed ID: 1942708
[TBL] [Abstract][Full Text] [Related]
2. Nucleolar organizer regions in bladder cancer: application to urinary cytology.
Masuda M; Nagamoto A; Hirokawa M; Takano Y; Shuin T
Urology; 1994 Aug; 44(2):194-8. PubMed ID: 8048194
[TBL] [Abstract][Full Text] [Related]
3. Role of the argyrophilic nucleolar organizer regions in tumor detection and prognosis.
Pich A; Chiusa L; Margaria E
Cancer Detect Prev; 1995; 19(3):282-91. PubMed ID: 7750118
[TBL] [Abstract][Full Text] [Related]
4. Comparison of argyrophilic nucleolar organizer regions (AgNORs) and mitotic index in distinguishing benign from malignant canine smooth muscle tumors and in separating inflammatory hyperplasia from neoplastic lesions of the urinary bladder mucosa.
Johnson GC; Miller MA; Ramos-Vara JA
J Vet Diagn Invest; 1995 Jan; 7(1):127-36. PubMed ID: 7779947
[TBL] [Abstract][Full Text] [Related]
5. [Study on nucleolar organizer regions in bladder neoplasm].
Takeuchi T
Nihon Hinyokika Gakkai Zasshi; 1990 Nov; 81(11):1711-9. PubMed ID: 2287118
[TBL] [Abstract][Full Text] [Related]
6. Interphase argyrophilic nucleolar organiser regions and nucleolar counts in transitional cell bladder tumours.
Korneyev IA; Mamaev NN; Kozlov VV; Rybakova MG; al-Shukri SH
Mol Pathol; 2000 Jun; 53(3):129-32. PubMed ID: 10897331
[TBL] [Abstract][Full Text] [Related]
7. Nucleolar and argyrophilic nucleolar organizer region counts in urothelial carcinomas with special emphasis on grade II tumors.
Helpap B; Loesevitz L; Bulatko A
Virchows Arch; 1994; 425(3):265-9. PubMed ID: 7812512
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the argyrophilic nucleolar organizer region, nuclear DNA content and mean nuclear area in transitional cell carcinoma of bladder using a quantitative image analyzer.
Shiina H; Urakami S; Shirakawa H; Shigeno K; Himeno Y; Mizutani M; Igawa M; Ishibe T
Eur Urol; 1996; 29(1):99-105. PubMed ID: 8821699
[TBL] [Abstract][Full Text] [Related]
9. Clinical value of argyrophilic organizer region in bladder transitional cell carcinoma.
Shiina H; Shirakawa H; Yokogi H; Kishi H; Mizutani M; Igawa M; Ishibe T
Urol Int; 1995; 54(2):74-9. PubMed ID: 7747363
[TBL] [Abstract][Full Text] [Related]
10. Two-dimensional agnor evaluation as a prognostic variable in urinary bladder carcinoma: a different approach via total agnor area/nucleus area per cell.
Cucer N; Imamoglu N; Tozak H; Demirtas H; Sarac F; Tatlisen A; Oztürk F
Micron; 2007; 38(6):674-9. PubMed ID: 17011198
[TBL] [Abstract][Full Text] [Related]
11. [Image analysis of AgNORs in esophageal balloon cytosmears].
Wang DY
Zhonghua Zhong Liu Za Zhi; 1993 Jan; 15(1):30-3. PubMed ID: 8334937
[TBL] [Abstract][Full Text] [Related]
12. AgNORs in benign, borderline and transitional cell neoplasms of the urinary bladder.
Misra V; Mukherjee J; Gupta SC; Tandon S; Gupta AK
APMIS; 1998 Oct; 106(10):987-92. PubMed ID: 9833702
[TBL] [Abstract][Full Text] [Related]
13. Fine needle aspiration cytology combined with argyrophilic nucleolar organizer regions (AgNORs) in diagnosis of thyroid neoplasms.
Szot W; Szybiński Z; Zaczek M; Kedra D; Dabroś E; Piotrowska K; Chłap Z
Endokrynol Pol; 1993; 44(4):413-26. PubMed ID: 7519978
[TBL] [Abstract][Full Text] [Related]
14. Morphometric analysis of argyrophilic nucleolar organizer regions (AgNORs) in nasopharyngeal carcinoma.
Pak MW; To KF; Chen MH; Lo SY; Lam PK; van Hasselt CA
Head Neck; 2000 Dec; 22(8):760-4. PubMed ID: 11084635
[TBL] [Abstract][Full Text] [Related]
15. Argyrophilic nucleolar organizer region in proliferating cell has a predictive value for local recurrence in superficial bladder tumor.
Tomobe M; Shimazui T; Uchida K; Hinotsu S; Akaza H
J Urol; 1999 Jul; 162(1):63-8. PubMed ID: 10379741
[TBL] [Abstract][Full Text] [Related]
16. [The proliferative potential of human pituitary macroadenomas on the basis of morphometric analysis of nucleolus organizer regions].
Szymaś J; Liebert W; Beil M
Neurol Neurochir Pol; 1999; 33(5):1089-97. PubMed ID: 10672560
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of DD23 as a marker for detection of recurrent transitional cell carcinoma of the bladder in patients with a history of bladder cancer.
Gilbert SM; Veltri RW; Sawczuk A; Shabsigh A; Knowles DR; Bright S; O'Dowd GJ; Olsson CA; Benson MC; Sawczuk IS
Urology; 2003 Mar; 61(3):539-43. PubMed ID: 12639642
[TBL] [Abstract][Full Text] [Related]
18. [Nucleolus organizer regions in pathomorphologic tumor diagnosis].
Rüschoff J
Veroff Pathol; 1992; 139():1-144. PubMed ID: 1413987
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic value of AgNOR method in thyroid cytopathology: correlation with morphometric measurements.
Solymosi T; Tóth V; Sápi Z; Bodó M; Gál I; Csanádi L
Diagn Cytopathol; 1996 Mar; 14(2):140-4. PubMed ID: 8964170
[TBL] [Abstract][Full Text] [Related]
20. Nucleolar organiser regions (AgNORs) as predictors in transitional cell bladder cancer.
Lipponen PK; Eskelinen MJ; Nordling S
Br J Cancer; 1991 Dec; 64(6):1139-44. PubMed ID: 1764378
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
